Variant Pharmaceuticals Has a New Name - ZyVersa Therapeutics, Inc.
Our Vision is to be recognized as a leading specialty biopharmaceutical company at the forefront of innovation for patients with unmet medical needs. We are committed to restoring health and transforming the lives of patients through development of novel biopharmaceutical products.
Our Mission is to develop first-in-class biopharmaceuticals that optimize health outcomes and improve patients’ quality of life. Our strategy to achieve this mission is to: